Immunocore Hldgs Q2 2024 GAAP EPS $(0.23) Beats $(0.45) Estimate, Sales $75.400M Beat $74.580M Estimate
Author: Benzinga Newsdesk | August 08, 2024 07:25am
Immunocore Hldgs (NASDAQ:
IMCR) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.45) by 48.89 percent. The company reported quarterly sales of $75.400 million which beat the analyst consensus estimate of $74.580 million by 1.10 percent. This is a 24.21 percent increase over sales of $60.704 million the same period last year.
Posted In: IMCR